Xi Jin
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- Cancer, Lipids, and Metabolism
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
-
- Breast Cancer Treatment Studies 11
- Cancer-related molecular mechanisms research 7
- Cancer, Lipids, and Metabolism 7
- Cancer Genomics and Diagnostics 5
-
- RNA modifications and cancer 7
- Co-authors
- Yi‐Zhou Jiang (29 shared papers)Da‐Qiang Li (8 shared papers)Zhi‐Ming Shao (14 shared papers)Ding Ma (10 shared papers)Xiao‐En Xu (12 shared papers)Zhi‐Ming Shao (20 shared papers)Yi-Zhou Jiang (8 shared papers)Ke‐Da Yu (7 shared papers)
- Journals
- Cancer Research (7 papers)World Journal of Gastroenterology (5 papers)Breast Cancer Research and Treatment (3 papers)BMC Cancer (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xi Jin
81 papers receiving 2.6k citations
Xi Jin's Hit Papers
Peers
Comparison fields: 5 of 110
- Cancer Research 895
- Oncology 571
- Pulmonary and Respiratory Medicine 628
- Molecular Biology 1.1k
- Immunology 297
Countries citing papers authored by Xi Jin
This map shows the geographic impact of Xi Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Jin more than expected).
Fields of papers citing papers by Xi Jin
This network shows the impact of papers produced by Xi Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Jin. The network helps show where Xi Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Xi Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy Hit paper breakdown → | 2022 | 437 |
| 2 | The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer Hit paper breakdown → | 2022 | 292 |
| 3 | 2016 | 175 | |
| 4 | 2016 | 161 | |
| 5 | 2019 | 99 | |
| 6 | 2011 | 92 | |
| 7 | 2020 | 71 | |
| 8 | 2021 | 63 | |
| 9 | 2023 | 62 | |
| 10 | 2010 | 58 | |
| 11 | 2013 | 56 | |
| 12 | 2015 | 52 | |
| 13 | 2023 | 44 | |
| 14 | 2021 | 42 | |
| 15 | 2022 | 41 | |
| 16 | 2011 | 41 | |
| 17 | 2019 | 41 | |
| 18 | 2009 | 39 | |
| 19 | 2015 | 35 | |
| 20 | 2023 | 34 |
About Xi Jin
Xi Jin is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 86 papers that have together received 2.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (8 papers), Cancer-related molecular mechanisms research (7 papers), Cancer, Lipids, and Metabolism (7 papers), RNA modifications and cancer (7 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Cancer Research (895 citations), Oncology (571 citations), Pulmonary and Respiratory Medicine (628 citations), Molecular Biology (1.1k citations) and Immunology (297 citations). Xi Jin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yi‐Zhou Jiang, Da‐Qiang Li, Zhi‐Ming Shao, Ding Ma, Xiao‐En Xu, Zhi‐Ming Shao, Yi-Zhou Jiang, Ke‐Da Yu, Gen‐Hong Di and Yi Xiao. Their work appears in journals such as Cancer Research, World Journal of Gastroenterology, Breast Cancer Research and Treatment, BMC Cancer and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.